APH.L - Alliance Pharma plc

LSE - LSE Delayed Price. Currency in GBp

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees200

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Jonathan ButterfieldCEO & Exec. Director328.99kN/A1976
Mr. Andrew Timothy FranklinCFO & Exec. Director241.9kN/A1966
Mr. Stephen KidnerChief Scientific & Operations OfficerN/AN/AN/A
Mr. Daniel ThomasChief Corp. Devel. OfficerN/AN/AN/A
Ms. Janice TimberlakeChief HR OfficerN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and sells pharmaceutical and healthcare products. It owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices. In addition, it offers products in various therapeutic areas, including acquired healthcare, cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology, travel health, urology, vitamins and minerals, and others. Further, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Xonvea, Flamma Franchise, Aloclair, Hydromol, Forceval, Haemopressin, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. The company distributes its products through wholesalers, retail pharmacies, hospitals, and network of distributors. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.